Govt notifies amendments to drugs, clinical trials rules to promote ease of doing business

The Centre has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, in line with the directions of Prime Minister Narendra Modi to reduce regulatory burden and promote ease of doing business.